Premium
Hyperparathyroidism‐jaw tumour syndrome
Author(s) -
Chen J. D.,
Morrison C.,
Zhang C.,
Kahnoski K.,
Carpten J. D.,
Teh B. T.
Publication year - 2003
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1046/j.1365-2796.2003.01168.x
Subject(s) - medicine , hyperparathyroidism , disease , pathological , genetic counseling , identification (biology) , primary hyperparathyroidism , bioinformatics , pathology , intensive care medicine , genetics , biology , botany
Abstract. Chen JD, Morrison C, Zhang C, Kahnoski K, Carpten JD, Teh BT (Van Andel Research Institute, Grand Rapids, MI; Ohio State University Comprehensive Cancer Center, Columbus, OH; and National Human Genome Research Institute, National Insitutes of Health, Bethesda, MD, USA). Hyperparathyroidism‐jaw tumour syndrome (Minisymposium). J Intern Med 2003; 253: 634–642. Amongst hyperparathyroidism‐related syndromes, hyperparathyroidism‐jaw tumour syndrome is one of the least common and relatively unknown but its clinical and genetic aspects are not less interesting or important. With the recent identification of its genes, we can now better characterize the disease, both clinically and genetically, which will certainly impact the field of endocrinology and oncology. In this article, we review the clinico‐pathological features and genetic basis of this syndrome with the hope that it will create awareness and interest in this disease amongst clinicians and basic scientists.